Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral nerve proteins and membranes refer to the ensemble of structural and functional proteins (such as PMP22, P0, and P2) and lipid bilayers that comprise the myelin sheath enveloping axons in the peripheral nervous system. These proteins are crucial for the assembly, stability, and function of the myelin membrane, which enables rapid electrical signal conduction. Mutations in major peripheral nerve proteins can result in hereditary neuropathies such as Charcot-Marie-Tooth disease and other demyelinating disorders. Peripheral nerve membranes also feature specialized transport and adhesion molecules and present unique barriers to drug delivery, making them therapeutic targets in inherited and acquired nerve injuries.
Mechanism of action can involve stabilization of protein folding (e.g., for PMP22 in CMT), modulation of membrane cholesterol and lipid composition, facilitation of nerve regeneration often via growth factor signaling, and barrier modulation to enhance drug delivery (e.g., via claudin-1 manipulation for analgesics to peripheral nerves).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral nerve proteins and membranes.